These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 6389093)

  • 21. Is conversion disorder biologically related with depression?: a DST study.
    Tunca Z; Fidaner H; Cimilli C; Kaya N; Biber B; Yeşil S; Ozerdem A
    Biol Psychiatry; 1996 Feb; 39(3):216-9. PubMed ID: 8837984
    [No Abstract]   [Full Text] [Related]  

  • 22. [Dexamethasone suppression test (DST): clinical use in psychiatry].
    Morrissette L; Boucher H
    Union Med Can; 1986 Jan; 115(1):58-63. PubMed ID: 3952894
    [No Abstract]   [Full Text] [Related]  

  • 23. [Influence of depressive history on biological parameters in major depression].
    Van Wijnendaele R; Hubain P; Dramaix M; Mendlewicz J; Linkowski P
    Encephale; 2002; 28(1):51-8. PubMed ID: 11963343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined dexamethasone/corticotropin-releasing hormone test in acute and remitted manic patients, in acute depression, and in normal controls: I.
    Schmider J; Lammers CH; Gotthardt U; Dettling M; Holsboer F; Heuser IJ
    Biol Psychiatry; 1995 Dec; 38(12):797-802. PubMed ID: 8750037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The dexamethasone suppression test in affective disorders. A review].
    Charles G; Wilmotte J; Mendlewicz J
    Acta Psychiatr Belg; 1982; 82(3):349-62. PubMed ID: 6299064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Co-occurring manic symptomatology influences HPA axis alterations in depression.
    Jabben N; Nolen WA; Smit JH; Vreeburg SA; Beekman AT; Penninx BW
    J Psychiatr Res; 2011 Sep; 45(9):1208-13. PubMed ID: 21450306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Plasma and saliva DST (dexamethasone suppression test) in depression. Clinical applications and kinetic approach].
    Piollet I; Lepine JP; Guechot J; Philip E; Rouillon F; Fiet J; Lajeunesse C; Villette JM; Dreux C; Lemperiere T
    Encephale; 1984; 10(6):279-80. PubMed ID: 6529934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An investigation of hypothalamic-pituitary-adrenal axis hyperactivity in anorexia nervosa: the role of CRH and AVP.
    Connan F; Lightman SL; Landau S; Wheeler M; Treasure J; Campbell IC
    J Psychiatr Res; 2007; 41(1-2):131-43. PubMed ID: 16455105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hormonal differences between psychotic and non-psychotic melancholic depression.
    Contreras F; Menchon JM; Urretavizcaya M; Navarro MA; Vallejo J; Parker G
    J Affect Disord; 2007 Jun; 100(1-3):65-73. PubMed ID: 17098292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The dexamethasone suppression test and response to somatic treatment: a review.
    Gitlin MJ; Gerner RH
    J Clin Psychiatry; 1986 Jan; 47(1):16-21. PubMed ID: 3510195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypothalamic-pituitary-adrenal axis function in survivors of childhood acute lymphoblastic leukemia and healthy controls.
    Gordijn MS; van Litsenburg RR; Gemke RJ; Bierings MB; Hoogerbrugge PM; van de Ven PM; Heijnen CJ; Kaspers GJ
    Psychoneuroendocrinology; 2012 Sep; 37(9):1448-56. PubMed ID: 22385687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Dexamethasone suppression test in patients with depression syndromes].
    Rybakowski J; Wesołowski Z; Jankowiak E; Walczak M
    Psychiatr Pol; 1986; 20(1):22-6. PubMed ID: 3725985
    [No Abstract]   [Full Text] [Related]  

  • 33. [Dexamethasone suppression test repeated after a suicide attempt].
    Wilmotte J; Van Wettere JP; Depauw Y; Charles G
    Acta Psychiatr Belg; 1986; 86(3):242-8. PubMed ID: 3751647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The dexamethasone suppression test in agoraphobia with panic attacks. 30 cases].
    Cottraux J; Claustrat B
    Encephale; 1984; 10(6):267-72. PubMed ID: 6529933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incorporating hypothalamic-pituitary-adrenal axis measures into preventive interventions for adolescent depression: are we there yet?
    Adam EK; Sutton JM; Doane LD; Mineka S
    Dev Psychopathol; 2008; 20(3):975-1001. PubMed ID: 18606040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathophysiology of HPA axis abnormalities in patients with major depression: an update.
    Kathol RG; Jaeckle RS; Lopez JF; Meller WH
    Am J Psychiatry; 1989 Mar; 146(3):311-7. PubMed ID: 2645793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical burnout is not reflected in the cortisol awakening response, the day-curve or the response to a low-dose dexamethasone suppression test.
    Mommersteeg PM; Heijnen CJ; Verbraak MJ; van Doornen LJ
    Psychoneuroendocrinology; 2006 Feb; 31(2):216-25. PubMed ID: 16150550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Value of the dexamethasone suppression test in a sample of sectorized patients].
    Gaillard P; Degiovanni A; Sizaret P; Chevrollier JP; Valat C
    Ann Med Psychol (Paris); 1984; 142(7):1001-7. PubMed ID: 6524799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Contributions of cortisol suppression tests to understanding of psychiatric disorders: a narrative review of literature].
    Tajima-Pozo K; Montes-Montero A; Güemes I; González-Vives S; Díaz-Marsá M; Carrasco JL
    Endocrinol Nutr; 2013; 60(7):396-403. PubMed ID: 23623464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The dexamethasone suppression test in repeated hospitalizations.
    Grunhaus L; Greden JF; Carroll BJ; Shein H
    Biol Psychiatry; 1983 Dec; 18(12):1497-502. PubMed ID: 6661477
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.